Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Stocks Open Lower After Six Weeks of Gains
Published: Monday, 20 Aug 2012
By: JeeYeon Park
Stocks opened slightly lower Monday as investors appeared to take a breather following the recent stealth rally that propelled the Dow and S&P 500 near four-year highs.
Still, hopes of further bond buying by the ECB helped limit losses...
It looks like I won't be getting a pullback anymore lol...
It looks like it really wants to break that $8 resistance, nice upside potential here.
BSPM. (China) Biostar Pharmaceuticals, Inc. Announces Receipt of "Army New Drug Certificate" for Zushima Spray
http://finance.yahoo.com/news/biostar-pharmaceuticals-inc-announces-receipt-110000688.html
AET. Insurer Aetna to buy Coventry Health for $5.6 billion
http://finance.yahoo.com/news/insurer-aetna-buy-coventry-health-044739725.html
(Reuters) - Insurer Aetna Inc said it will buy rival Coventry Health Care Inc for $5.6 billion in cash and stock to boost its share of government business and benefit from U.S. healthcare reforms.
The U.S. healthcare reform aims to provide coverage for 16 million more Americans through privately run health insurance exchanges in each state, and will expand Medicaid eligibility for an additional 16 million people by raising limits on household income.
The acquisition of Coventry will help Aetna lift its share of revenue from its government business to over 30 percent from 23 percent.
It will help Aetna add nearly 4 million medical members and 1.5 million Medicare Part D members. Medicare Part D is a federal program that reduces prescription drug costs for Medicare beneficiaries.
"Integrating Coventry into Aetna will complement our strategy to expand our core insurance business, increase our presence in the fast-growing government sector and expand our relationships with providers in local geographies," Aetna's CEO Mark Bertolini said in a statement.
DEAL DETAILS
Aetna will pay $27.30 in cash and 0.3885 shares for each Coventry share held, a total value of $42.08 per share, Coventry and Aetna said in a joint statement.
The deal is at a 20.4 percent premium to Coventry's Friday closing stock price of $34.94.
Shares of Coventry rose above the offer price, gaining 21 percent to $42.15 in premarket trade on Monday.
Including the assumption of Coventry debt, the sale is valued at $7.3 billion, the companies said.
Aetna said it expects to finance the cash portion of the transaction with a combination of cash on hand and by issuing about $2.5 billion of new debt and commercial paper.
The deal is expected to add modestly to Aetna's operating earnings per share in 2013, 45 cents in 2014 and 90 cents in 2015.
Aetna's shares closed at $38.04 on Friday on the New York Stock Exchange.
In July, health insurer WellPoint Inc said it would buy rival Amerigroup Corp for $4.46 billion, nearly doubling its Medicaid business.
Last October, Cigna Corp agreed to buy HealthSpring Inc for $3.8 billion to strengthen its Medicare business.
SHP. ShangPharma Announces Second Quarter 2012 Results
http://finance.yahoo.com/news/shangpharma-announces-second-quarter-2012-100000979.html
SHANGHAI, Aug. 20, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the second quarter ended June 30, 2012.
Second Quarter 2012 Highlights
Net revenues increased by 15.7% year-over-year to $31.8 million.
Net revenues from the Company's top-10 customers increased by 21.3% year-over-year to $20.6 million, representing approximately 64.8% of total net revenues.
Net revenues from full-time-equivalent ("FTE")-based services increased by 21.0% year-over-year to $23.9 million.
GAAP gross margin was 27.8%, compared with 33.3% in the second quarter of 2011. Non-GAAP gross margin was 29.0%, compared with 34.7% in the second quarter of 2011.
GAAP operating margin was 2.4%, compared with 10.3% in the second quarter of 2011. Non-GAAP operating margin was 7.6% compared with 15.2% in the second quarter of 2011.
Sirius XM: RBC Capital Markets Analyst David Bank Reiterates $2.00 Price Target
August 20, 2012
By Demian Russian
With a new research report issued on the heels of Sirius XM Radio's (NASDAQ:SIRI) Q2 earnings results and conference call, RBC Capital Markets Global Media Analyst David Bank maintains his previous Sector Perform/Speculative Risk rating and reiterates his $2.00 price target on Sirius XM Radio's stock.
"Solid fundamentals, but valuation is relatively full."
- David Bank, RBC Capital Markets
While Bank describes Sirius XM's second quarter results as being "solid" and notes that "expense trends are stronger than we'd have expected," he views management's full-year 2012 adjusted EBITDA guidance increase from $875 million to ~$900 million as being "modest" and "roughly in-line with prior consensus."
Bank expects Sirius XM will have to pay more in music royalties as a percentage of revenue following a Copyright Royalty Board (CRB) decision on Sirius XM's music royalty payment requirements expected in late 2012. While Bank expects a modest increase in the company's music royalty expenses on this decision, he says forward estimates are already discounting this.
As the recent price increase rolls out, now affecting ~50% of the subscriber base, Bank sees key drivers remaining steady, citing a Q2 conversion rate of ~45% and a ~1.9% self-pay churn rate. "While we assume new car OEM penetration will remain ~66%, we estimate there are ~23mm inactive radios on the road which will help drive net additions as the used car market matures," Bank said. He also noted his expectation for a decline in full-year 2013 paid promotional net subscriber additions, due to a reclassification of General Motors (NYSE:GM) promotional subscribers. As a result of the renegotiated terms under the new GM contract, Bank expects GM's promotional subscribers to no longer be counted as "paid promotional" subscribers.
Bank sees Sirius XM's FCF (Free Cash Flow) as likely continuing to grow materially over the next few years. With Sirius XM management continuing to indicate that they are not seeing any strategically important acquisition targets out there, Bank sees Sirius XM's FCF generation conceivably fueling stock buybacks amounting to over $500 million a year in the next few years.
Noting that Sirius XM CEO Mel Karmazin's employment contract expires at the end of the year, Bank expects some indication of progress regarding negotiations with Sirius XM's board to come on the third quarter earnings call.
Commenting on Sirius XM's current situation with Liberty Media (NASDAQ:LMCA), Bank said, "SIRI isn't really in control of it's own destiny, but then again, what public company is (though most don't have a 45% single shareholder)?"
Several previous Playground Radio interviews with RBC Capital Markets Global Media Analyst David Bank are available for streaming or download in the Playground Radio Archive.
Disclosure: Long SIRI
This article was sent to 6,936 people who get email alerts on SIRI.
Facebook Investors Brace for More Shares Coming to Market
By Brian Womack and Aaron Ricadela - Aug 20, 2012 1:07 AM ET
Facebook Inc. (FB) shares, which fell to a record low after insiders could sell stakes for the first time since the initial public offering, will face more pressure when another 1.44 billion shares are freed up through November.
Facebook last week unlocked 271.1 million shares, the first of five insider sale restrictions scheduled during its first year as a public company.
By May the number of shares on the market will increase by 1.91 billion, compared with 421.2 million shares at the IPO.
While Facebook Chief Executive Officer Mark Zuckerberg operates the world’s largest social-networking service, he’s facing investor concerns about how it can generate more revenue from its growing user base. That, plus the end of the first lock-up, drove the shares to half the offering price of $38, wiping out almost $46 billion in market value.
“Is this something impatient or nervous investors should be worried about?” said Herman Leung, analyst at Susquehanna International Group. “Yes, but for the long-term investors, I view this as an opportunity to potentially get a stock at a pretty good price.”
Regulatory filings as soon as this week will disclose how many major shareholders sold their stock. Insiders are seen selling about 55 percent of the 1.2 billion shares that are set to come unlocked on Nov. 14, according to an Aug. 9 research note by Brian Wieser at Pivotal Research in New York.
Hedge funds that are using so-called short sales to benefit from the stock’s decline may be active ahead of mid-November, said Jay Ritter, professor of finance at the University of Florida. These investors will probably sell shares with the aim of buying them back at a discount at a later date, he said.
‘Selling Pressure’
“There will be selling pressure before the Nov. 14 lockup expires,” said Ritter, based in Gainesville, Florida.
Ashley Zandy, a spokeswoman for Menlo Park, California- based Facebook, declined to comment.
The shares dropped 4.1 percent to $19.05 at the close in New York on Aug. 17. Just before trading ended, Facebook touched a record intraday low of $19. More than 129 million shares were traded, after 157.6 million a day earlier when the lock-up expired, above the daily average volume of 48.7 million.
By May the number of shares on the market will increase by 1.91 billion, compared with 421.2 million shares at the IPO.
Facebook’s first earnings report as a public company last month also fueled concerns over how quickly it can draw revenue from mobile devices. Second-quarter revenue grew 32 percent from a year earlier, down from 45 percent in the first quarter.
Facebook’s mobile advertising services are a key concern for investors as more users turn to tablets and smartphones. The company should benefit in the coming months from new tools and services that help companies market their wares to users on the go, said Scott Kessler, an analyst at S&P Capital IQ.
Real Questions
“The fundamentals are better than people think,” said Kessler. Two days before the lock-up ended, he had upgraded the shares to buy and said that while there are real questions about the company, annual revenue growth should be at least 25 percent for the next three years.
Early Facebook investors such as DST Global Ltd., Goldman Sachs Group Inc. (GS), Elevation Partners and Accel Partners could start selling part of their holdings last week, Facebook has said in filings. Microsoft Corp. (MSFT), based in Redmond, Washington, was likely to hang on to its stake after the lock-up ban lifts, a person with knowledge of the matter said on Aug. 10. Microsoft views Facebook as a strategic partner against Google Inc. (GOOG), rather than as a near-term moneymaker, said the person, who requested anonymity because the plans are private.
Wild Card
Other investors have been preparing for potential sales. Director Peter Thiel, who sold in the IPO, gave himself more flexibility to unload holdings, according to a regulatory filing. One of Facebook’s earliest investors, Thiel converted more than 9 million shares to Class A from Class B. Class A shares are easier to sell on the public markets.
The shares freed up last week represent 14 percent of the 1.91 billion that will become available for sale in the coming nine months. The next expiration date comes between Oct. 15 and Nov. 13, when restraints are removed on about 243 million shares. Lock-up expires on about 1.2 billion shares on Nov. 14, and for 149.4 million shares a month later. A final round comes May 18, 2013, with 47.3 million shares becoming available.
The stock being sold Nov. 14 would include shares from current and former employees, as well individuals who bought stock from them, Pivotal Research’s Wieser said in his note.
“This date becomes the greatest wild card,” he wrote. “As the base of shareholders eligible to sell will be much more fragmented, orderly outcomes become much more uncertain.”
To contact the reporters on this story: Brian Womack in San Francisco at bwomack1@bloomberg.net; Aaron Ricadela in San Francisco at aricadela@bloomberg.net
To contact the editor responsible for this story: Tom Giles at tgiles5@bloomberg.net
WSJournal. video. Europe's Week Ahead: Glencore, Heineken, Euro
http://on.wsj.com/Q72l3v
Nice, will repost.
Here's Who Has Lost the Most on Facebook So Far
http://www.bloomberg.com/video/here-s-who-has-lost-the-most-on-facebook-so-far-DWTJgmqUQJ2cRX6n~b1UlA.html
A buyback would shoot the PPS higher. I've always played SIRI frequently in the past (long position but haven't played it in months)...hopefully I'll get a nice entry when/if it starts to pullback a bit.
Now that's one stock I would have liked to own :)
DFS. Discover Partners with Google Wallet. Analyst Blog
http://ih.advfn.com/p.php?pid=nmona&article=53868828
Sirius XM: Liberty Withdraws FCC Application And Refiles For Total Control
August 18, 2012
Sirius XM (SIRI) has filed an 8-k with the SEC that says Liberty Media (LMCA) plans to increase its ownership of Sirius to more than 50%. The company has now, in a separate document, withdrawn its application for de facto control of Sirius and simultaneously filed a new application with the FCC that it wants De Jure Control of Sirius, and plans to complete the takeover within 60 days of consent from the Commission. The document also states that Sirius will give its full cooperation, and it is signed by Sirius CFO David Frear:
On August 17, 2012, Liberty Media Corporation filed with the Federal Communications Commission ("Commission") an Application for Consent to Transfer of De Jure Control (the "Application"). In the Application, Liberty Media indicates, among other things, that it "intends to purchase sufficient additional shares of Sirius common stock such that, upon conversion of its Preferred Shares, it will own more than 50% of the total outstanding shares of Sirius…." Liberty Media also noted that it will "have purchased sufficient shares of Sirius' common stock and will convert its Preferred Shares such that the transfer of control will be completed within 60 days of Commission consent."The Company will cooperate fully with the Commission in its evaluation of the Application.
So a lot of the speculation is over. We can now assume that Liberty's actions this week were due to the fact that the FCC would have required the company to buy enough Sirius shares to go into hard control. This is a great relief to me, because otherwise the FCC would have set a precedent that 46.2% was the new 50%. This explains why Liberty went on the sudden buying spree and upped its stake to 48%. But, because Liberty will still need the additional 3% or more of Sirius shares, this should solidify the current stock price, which has been hovering between $2.55 and $2.60 today. And this may now be the new base price; as the shares can finally take off. This is also huge, because it appears that this time Sirius has given its blessing to the application.
We can now expect a share buyback, which will give Liberty even more of a chunk. If the FCC approves the current application before the company converts its Preferred shares, it could structure a buyback, which the Preferred shares do not participate in, giving Liberty shareholders a larger piece of the pie. As to whether that will happen now, is in the hands of the FCC. They could force Liberty to convert the Preferred shares, but I doubt that they will. In the application, Liberty states that the shares would be converted within 60 days of FCC approval. That is plenty of time to do a buyback, which the company is probably already planning right now.
A Sirius buyback, as I have written about several times will lessen the float and make all of the shares worth more. The price could easily go over $3.50 if all of the Sirius cash is used for the buyback. With less shares, all of the financials look even better than they already do. The P/E goes even lower, and the EPS goes even higher. So, if this is what indeed happens, it will be a win-win for everyone that kept their stock. But, again this must have the blessing of the FCC first.
In lesser news, CEO Mel Karmazin filed a separate SEC document reporting that he did sell 15.9 million of his "charity shares" on August 15 and 16. This was anticipated, as the sales pattern seems to land around the 15th of the month each time. And Liberty also filed another SEC document showing that the company bought another 4.35 million shares of Sirius on the same days that Karmazin sold. Since Liberty will need a lot more shares to bring its ownership to over 50%, we can look forward to more filings like this.
Whether you were for or against Liberty taking control of Sirius, it is in the best interest of both companies to have this situation resolved. I think we can now safely say it's almost over, because if the FCC approves the new application, Liberty takes control. And if the FCC denies it (which I do not anticipate now), Sirius will continue on its own as usual.
Where will Sirius go from here? According to an interview with The Wall Street Journal at the annual Allen & Co. conference in Sun Valley last month:
Liberty Media Chairman John Malone said he is more concerned about evolving technologies than Mr. Karmazin, who has been Sirius's chief executive since 2004, appeared to be.
"I'm a very long-term investor, despite my age," said Mr. Malone, who is 71.
"So I tend to be looking out 10 or 20 years, whereas I think Mel in all honesty right now has got a pretty short-term focus. I think they do an excellent job of running the company but we would be making more investments and...would at least look at globalizing."
There has been a lot of speculation as to whether Karmazin would stay with Sirius if Liberty did take De Jure control. However, he put some of that speculation to rest when he talked about the idea on the last Q2 earnings call. In spite of the rumors that he would want to leave, he said that he will stay, provided that he and the Sirius Board come to an agreement:
I think that I'm the biggest believer in free speech and I don't question anyone's ability to do the right things. But the fact that I was asked a question two years ago about working for somebody and I told them that my experience at Viacom was such that I didn't enjoy and I like working for a Board as compared to working for a controlling shareholder was something that I said. And then every time the discussion of Liberty comes up somebody is coupling my name into that.
I can assure you that our Board and I are interested in trying to accomplish whatever Liberty wants to do as long as it's in all of our shareholders' best interests and that there is no issue involving Mel that has anything to do with the current conversations with Liberty at all. Regarding my contract, it doesn't expire until the end of the year, and prior to the Q3 earnings call, prior to our next call I think the Board and I will deal with it.
This was a relief to a lot of Sirius investors, who believe that Karmazin has been one of the main reasons that Sirius is where it is today. He has led the company through some of the darkest times in our economy since the Great Depression. And Sirius has outperformed any of the other Liberty companies during that time.
That may have been one of the things on Malone's mind when he made another remark at the Sun Valley conference about the issue of Karmazin leaving the company:
Liberty had no intention of taking operating control of Sirius away from Karmazin. "I love Mel," he said. "We hope he is happy."
The prospect of a Sirius share buyback, combined with the exceptional Q2 earnings and future guidance will send the shares soaring short term. And there is no reason to think that the company will not continue to grow like it has over the last couple of years. The icing on the cake will be if Mel stays, and Malone implements some of his investment ideas for the future of Sirius. As to what type of spin-off is planned, that is hard to know for sure. We could speculate for hours on something that Malone may not even know the answer to yet. But at least short term, the shares could be headed for three to four dollars with a buyback.
Disclosure: I am long SIRI.
DDD. 3-D PRINTING. INFO SHEET (updated).
WebSite. http://www.3dsystems.com/
iHub. http://ih.advfn.com/p.php?pid=squote&symbol=ddd
Investor Presentation.
http://investor.3dsystems.com/sites/default/files/downloads/April-2012-Investor-Presentation.pdf
Another record revenue quarter
http://ih.advfn.com/p.php?pid=nmona&article=53606177
10-Q 7/26/12
Shares of Common Stock, par value $0.001, outstanding as of July 20, 2012: 55,402,822
incease of about 4 million shares since last quater.
http://ih.advfn.com/p.php?pid=nmona&article=53605816
8/13/12 3D Systems Launches Cubify Earrings
http://ih.advfn.com/p.php?pid=nmona&article=53804544
8/8/12 3D Systems' Full Color Printers Bring LAIKA's ParaNorman to Life
http://ih.advfn.com/p.php?pid=nmona&article=53751669
8/7/12 3D Systems Kicks Off the Cubify Challenge at Siggraph
http://ih.advfn.com/p.php?pid=nmona&article=53738173
8/6/12 3D Systems Launches Cubify Tags
http://ih.advfn.com/p.php?pid=nmona&article=53724722
8/6/12 3D Systems Kicks it Up a Notch at Siggraph
http://ih.advfn.com/p.php?pid=nmona&article=53721577
8/3/12 3D Systems Brings On-Demand Aerospace Manufacturing Solutions to AUVSI
http://ih.advfn.com/p.php?pid=nmona&article=53704556
7/31/12 3D Systems Launches Cubify Robots
http://ih.advfn.com/p.php?pid=nmona&article=53660671
7/24/12 Launches Cubify Invent. 3D design tool. $49.
http://ih.advfn.com/p.php?pid=nmona&article=53575612
7/23/12 3D Systems Acquires Viztu Technologies
http://ih.advfn.com/p.php?pid=nmona&article=53563551
7/12/12 3Shape’s Dental System™
http://www.3dsystems.com/press-releases/3d-systems-dental-printer-makes-3shape-grade
6/28/12 “Smarter 3D Printing” Seminars near you.
http://www.3dsystems.com/press-releases/3d-systems-brings-smarter-3d-printing-seminars-your-area
6/27/12 USP Class VI certification, including biocompatibility
http://www.3dsystems.com/press-releases/3d-systems-expands-class-vi-certified-materials-projettm-series
Entire range of 3D content-to-print products and services:
http://www.printin3d.com/
http://www.production3dprinters.com/
http://www.toptobottomdental.com/
http://www.3dproparts.com/
http://www.quickparts.com/
http://www.alibre.com/
http://www.bitsfrombytes.com/
http://www.the3dstudio.com/
http://www.freedomofcreation.com/
http://www.sycode.com/
http://www.botmill.com/
http://blog.3dsystems.com/
http://www.cubify.com/
Apply to Become a Reseller Today!
http://printin3d.com/reseller-opportunities
> Big Boards scans - Friday Aug 17 Gainers
Top 20 charts posted.
20%+ gainers
None
10%-20% gainers
OPLK 16.31 2.05 14.38%
PAL 1.82 0.18 10.98%
5%-10% gainers
ATPG 0.46 0.04 8.71%
VIP 10.80 0.78 7.78%
IMOS 14.55 1.02 7.58%
LEAP 6.39 0.45 7.58%
WPP 9.34 0.63 7.23%
KCAP 8.68 0.56 6.90%
TEA 12.27 0.77 6.70%
GTAT 6.55 0.41 6.68%
HGG 7.29 0.42 6.11%
MIG 7.51 0.42 5.92%
HZNP 4.48 0.24 5.66%
KORS 52.09 2.56 5.17%
UBNT 8.65 0.42 5.10%
Others
DECK 50.77 2.35 4.86%
MPO 7.90 0.35 4.64%
SREV 8.50 0.35 4.29%
AVEO 9.48 0.38 4.18%
INOD 3.72 0.14 3.91%
AXTI 3.21 0.12 3.88%
NOK 2.74 0.10 3.79%
AZC 2.98 0.10 3.47%
MTG 1.23 0.04 3.36%
SVNT 1.00 0.03 3.34%
ALC 7.45 0.24 3.33%
ARNA 8.08 0.26 3.32%
EZCH 30.81 0.98 3.29%
OTT 2.17 0.06 2.84%
SGMS 6.89 0.19 2.84%
GSV 1.46 0.04 2.82%
ENOC 9.86 0.26 2.71%
DNDN 4.94 0.13 2.70%
GNTX 18.72 0.49 2.69%
OPEN 44.57 1.16 2.67%
FOSL 89.80 2.01 2.29%
NUVA 21.45 0.46 2.19%
AUQ 6.60 0.14 2.17%
VPHM 26.12 0.54 2.11%
VSAT 39.35 0.81 2.10%
FACE 4.30 0.09 2.02%
DTSI 21.95 0.43 2.00%
http://stockcharts.com/c-sc/sc?s=OPLK&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=PAL&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=ATPG&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=VIP&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=IMOS&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=LEAP&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=WPP&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=KCAP&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=TEA&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=GTAT&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=HGG&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=MIG&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=HZNP&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=KORS&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=UBNT&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=DECK&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=MPO&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=SREV&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=AVEO&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=INOD&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
LLY. FDA approves updated prescribing information for Tradjenta® (linagliptin) tablets for add-on therapy to insulin in adults with type 2 diabetes
Updated label also includes data on adult patients with type 2 diabetes who have severe chronic renal impairment, providing further evidence TRADJENTA is an efficacious DPP-4 inhibitor with a demonstrated safety profile
http://finance.yahoo.com/news/fda-approves-updated-prescribing-information-185200943.html
MYL. Mylan Launches Generic Actoplus Met® Tablets and Generic Actos® Tablets
-Company granted 180 days marketing exclusivity on both products-
http://finance.yahoo.com/news/mylan-launches-generic-actoplus-met-165100353.html
Big Board Bios (Friday).
StocksDiva
http://investorshub.advfn.com/StocksDiva-Bio-Bin-16112/
Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), announced it has enrolled the first patients in its double-blind, randomized clinical study evaluating an advanced Microcyn® hydrogel for management of hypertrophic or keloid scars under an FDA-reviewed protocol.
The company plans to complete its 40-patient trial and provide top-line data by mid-2013 calendar year. The study design calls for recruitment of up to 40 patients at four different U.S. sites, which are Albuquerque, NM, High Point, NC, Austin, TX and College Station, TX.
DARA BioSciences, Inc. (Nasdaq: DARA) announced it has entered into an exclusive distribution agreement with Seyer Pharmatec Inc. for the sale and distribution of Soltamox (tamoxifen citrate, oral solution) in the Commonwealth of Puerto Rico. DARA plans to launch Soltamox later this year.
After a competitive multi-state process, Accelr8 Technology Corporation (NYSE MKT: AXK) today announces that it is moving its headquarters from Denver, CO to Tucson, AZ.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, today reported preliminary results from Phase 1 studies of LX2931 and LX7101.
Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY) today announced that it has completed patient enrollment in its U.S. Phase I clinical trial using REOLYSIN in combination with FOLFIRI (Folinic Acid (leucovorin) with Fluorouracil (5-FU) and Irinotecan) in patients with oxaliplatin refractory, Kras mutant colorectal cancer (REO 022).
Oncolytics Biotech Inc. (TSX:ONC) (NASDAQ: ONCY) today announced that it has completed patient enrollment in its U.K. Phase I clinical trial using intravenously-administered REOLYSIN in combination with cyclophosphamide in patients with advanced malignancies (REO 012).
Perrigo Company (Nasdaq: PRGO; TASE) today announced results for its fourth quarter and full year ended June 30, 2012.
WuXi PharmaTech (NYSE: WX) today announced that its toxicology facility in Suzhou had received a Certificate of Good Laboratory Practice (GLP) from the State Food and Drug Administration (SFDA) of the People's Republic of China after successfully passing two GLP inspections conducted by the SFDA.
MGM and AAPL update: New highs!
MGM: hit $10.60
AAPL: hit a new high of $648.19
Time to short if it breaks $19? I need to find those pre IPO prices on the secondary market for potential supports.
lol I didn't buy any, so I'm not worried :)
FB $19 low of day - half price what they ipo'd ... Sick !
FB $19.01 ...
Just make sure they won't trade their 'Y' for an 'H' ... j/k
Yea, I'm thinking of pulling the trigger on shorting it, but something is holding me back lol.
I'm looking into YELP right now, but haven't decided if I want to jump in just yet...One of the board members/investors of YELP also took part in LNKD and said that "those two seemed to have gotten it right." Time is running out and I need to make a decision fast lol.
FB ... hum ! Could see below $19 today ...
< $19.05 now, $19.01 lod >
Hi Charles ... nope, was not watching
Did you see the bounce on FNMA today? Crazy stuff!
I missed it unfortunately...
lol There goes that $20 support analysts were hoping it would hold...now where's the bottom for a "fair valuation" on the stock?
Morning :)
10:00am update
Symbol %Change Last High Change
OPLK +14.52% 16.33 16.49 +2.07
DATE +12.61% 5.00 5.21 +0.56
GTAT +7.82% 6.62 6.96 +0.48
MIG +5.64% 7.49 7.57 +0.40
GSV +4.93% 1.49 1.63 +0.07
NOK +3.75% 2.7389 2.76 +0.0989
IMOS +3.55% 14.00 14.24 +0.48
HGG +3.49% 7.11 7.15 +0.24
YGE +3.06% 2.02 2.04 +0.06
MPO +2.91% 7.77 7.85 +0.22
IDIX +2.40% 5.98 6.11 +0.14
R +2.28% 42.55 42.76 +0.95
AAPL Update: $640 target reached!
OPLK - OPLK FYQ4 EPS Beats, Q1 EPS View Higher
By Tiernan Ray
Shares of fiber optic component vendor Oplink Communications (OPLK) are up 30 cents, or 2%, at $14.56 after the company this afternoon reported fiscal Q4 revenue and profit per share that topped analysts’ expectations, and forecast this quarter’s EPS above consensus despite a revenue projection that was slightly below expectations.
Revenue in the three months ended in June rose slightly, year over year, to $44 million, yielding EPS of 19 cents.
Analysts on average had been modeling $44.5 million and 12 cents.
CEO Joe Liu called the quarter’s results “solid … especially considering the market climate in telecommunications spending.”
“As we enter fiscal 2013, we expect a relatively stable order environment,” he added, “although we are still limited in our visibility overall.”
For the current quarter, the company sees revenue in a range of $43 million to $46 million, and EPS, excluding some costs, of 16 cents to 22 cents.
Analysts have been modeling $46.1 million and 15 cents.
Oplink’s report follows a better-than-expected fiscal Q4 report by competitor JDS Uniphase (JDSU) on Tuesday.
Oplink Reports Fourth Quarter and Fiscal Year 2012 Financial Results
MRVL - MRVL Falls 7%: FYQ2 Rev, EPS Miss
By Tiernan Ray
Chip maker Marvell Technology Group (MRVL) this afternoon reported fiscal Q2 revenue and earnings per share that missed analysts’ estimates, citing the effect of global economic weakness.
Revenue in the three months ended in July fell 9%, year over year, and rose 2% from the prior quarter, to $816 million, yielding EPS of 24 cents, lower than the average estimate for $853 million and 26 cents.
Gross margin in the quarter, on a non-GAAP basis, fell to 53.6% from the prior quarter’s 54.5% and from 57.9% in the prior-year period.
CEO Sehat Sutardja remarked that “Our results in the second quarter were affected primarily by the slowdown in the macro-economic environment that impacted our storage and mobile end markets.”
However, he added, “Despite the soft near-term demand environment, we are maintaining good profitability and continue to deliver shareholder value through our share repurchase and dividend programs.”
He noted the success of the company’s “solid-state drive” controller chips, its chips for 500-gigabyte hard drives, and its wireless connectivity products.
Marvell shares this afternoon are down 80 cents, almost 7%, at $11.48.
Marvell Technology Group Ltd. Reports Second Fiscal Quarter 2013 Financial Results
AVGO - Avago Technologies Limited Announces Third Quarter Fiscal Year 2012 Financial Results
GlobeNewswirePress Release: Avago Technologies – 49 minutes ago
Net revenue up 5.0 percent sequentially to $606 million, up 0.5 percent from Q3 last year
GAAP gross margin of 48.7 percent; Non-GAAP gross margin of 51.2 percent
GAAP earnings per diluted share of $0.58; Non-GAAP earnings per diluted share of $0.72
SAN JOSE, Calif. and SINGAPORE , Aug. 16, 2012 (GLOBE NEWSWIRE) -- Avago Technologies Limited (AVGO), a leading supplier of analog interface components for communications, industrial and consumer applications, today reported financial results for the third quarter of its fiscal year 2012, ended July 29, 2012, and provided guidance for the fourth quarter of its fiscal year 2012.
Third Quarter Fiscal Year 2012 GAAP Results
Net revenue was $606 million, an increase of 5.0 percent compared with the previous quarter and 0.5 percent from the same quarter last year.
Gross margin was $295 million, or 48.7 percent of net revenue. This compares with gross margin of $278 million, or 48.2 percent of net revenue last quarter, and gross margin of $297 million, or 49.3 percent of net revenue in the same quarter last year.
Operating expenses were $146 million. This compares with $141 million in the prior quarter and $152 million for the same quarter the previous year.
Income from operations was $149 million. This compares with $137 million in the prior quarter and with $145 million in the same quarter last year.
Third quarter net income was $145 million, or $0.58 per diluted share. This compares with net income of $134 million, or $0.54 per diluted share for the prior quarter, and net income of $144 million, or $0.57 per diluted share in the same quarter last year.
The Company's cash balance at the end of the third quarter was $973 million, compared to $954 million at the end of the prior quarter.
The Company generated $128 million in cash from operations in the third quarter and spent $65 million on capital expenditures.
On June 29, 2012 the Company paid a quarterly cash dividend of 15 cents ($0.15) per ordinary share, totaling approximately $37 million.
Read more ...
BRCD - Brocade Reports Fiscal Q3 2012 Results
Revenue Growth of 10% and Improved Margins Drove Higher EPS Yr./Yr.
MarketwirePress Release: Brocade – 40 minutes ago
SAN JOSE, CA--(Marketwire -08/16/12)- Brocade® (BRCD) today reported financial results for its third fiscal quarter ended July 28, 2012. Brocade reported third quarter revenue of $555.3 million, representing an increase of 10% year-over-year and 2% quarter-over-quarter. The resulting GAAP diluted earnings per share of $0.09, was up from break-even EPS in Q3 2011, and non-GAAP diluted EPS of $0.14, was up 59% year-over-year.
"Fiscal Q3 was a great quarter for Brocade. With continued differentiation in our products and focused execution across our organization, we were able to overcome many issues in the current challenging macroeconomic environment. As a result, our financial performance in the quarter exceeded our expectations for revenue, operating margin and earnings per share," said Michael Klayko, CEO of Brocade.
Summary of Q3 2012 results:
Storage business revenue, including products and services, was $377.6 million, up 13% year-over-year and down 6% sequentially. Storage product revenue increased 17% year-over-year and decreased 6% sequentially, in a seasonally soft quarter for the company. Brocade's industry-leading 16 Gbps Fibre Channel products represented nearly 30% of director and switch revenue in the quarter.
Ethernet business revenue, including products and services, was $177.8 million, up 5% year-over-year and up 24% quarter-over-quarter. Revenue growth for the Ethernet business was driven by an increase in Federal sales, which were up 40% year-over-year and 108% quarter-over-quarter. Enterprise business revenue was up 2% year-over-year and up 21% quarter-over-quarter as the Brocade ICX products continue to ramp. Service provider business revenue was up slightly quarter-over-quarter and down 5% year-over-year.
GAAP gross margin was 61.3% and non-GAAP gross margin was 63.7% in Q3 2012, compared to 61.0% and 61.8% in Q3 2011, respectively. The year-over-year improvement in gross margin was due to higher revenue, favorable product mix and lower fixed costs. Gross margin declined sequentially, as expected, driven by a greater mix of lower margin Ethernet revenue in Q3 2012.
GAAP operating margin was 12.6% and non-GAAP operating margin was 19.5% in Q3 2012, compared to 6.8% and 14.0% in Q3 2011, respectively. The year-over-year improvement in operating margin was due to higher revenue and expanded gross margin in Q3 2012. Operating margin improved quarter-over-quarter on higher revenue and lower operating expenses.
Operating cash flow was $113.1 million in Q3 2012. During the quarter, the Company reduced its term loan by $40.0 million. The remaining term loan balance was $30.0 million exiting the quarter.
GAAP EPS was $0.09 in Q3 2012, and non-GAAP EPS of $0.14 was up 59% year-over-year, which marks the fourth consecutive quarter of non-GAAP EPS year-over-year growth of nearly 20% or more.
Average diluted shares outstanding for Q3 2012 were lower by 40.0 million shares from Q3 2011, principally from share repurchases during the past year including 8.7 million shares ($45 million) repurchased during Q3 2012.
Brocade management will host a conference call to discuss fiscal third quarter results and fiscal fourth quarter outlook today at 2:30 p.m. PT (5:30 p.m. ET). To access the webcast please go to www.brcd.com/events.cfm. A replay of the conference call, prepared comments and slides as well as a written transcript, will be available at www.brcd.com.
Other Q3 2012 product, customer and partner announcements are available at http://newsroom.brocade.com/.
Brocade (www.brocade.com)
130 Holger Way, San Jose, CA. 95134
T. 408.333.8000 F. 408.333.8101
Read more ...
ARO - Aeropostale Earnings: Net Income Falls, Shares Drop 7%
By Derek Hoffman | More Articles
August 16, 2012
Aeropostale Inc. (NYSE:ARO) reported a lower net income in the second quarter compared with a year earlier, falling below analysts’ estimates. Aeropostale is a mall-based retailer that sells casual apparel and accessories for young adults.
Aeropostale Reports Results For Second Quarter Of Fiscal 2012
Second Quarter Earnings of $0.00 Per Diluted Share
Provides Third Quarter Guidance
PR NewswirePress Release: Aeropostale, Inc. – 50 minutes ago
NEW YORK, Aug. 16, 2012 /PRNewswire/ -- Aeropostale, Inc. (ARO), a mall-based specialty retailer of casual apparel for young women and men, today reported results for the second quarter of fiscal 2012, and provided guidance for the third quarter of fiscal 2012.
Second Quarter Performance
Net income for the second quarter of 2012 was approximately $0.1 million, or $0.00 per diluted share. Net income for the second quarter of 2011 was $2.9 million, or $0.04 per diluted share, which included a non-recurring pre-tax benefit to the Company's gross profit of $8.7 million, or $0.06 per diluted share, which resulted from the resolution of a dispute with one of the Company's sourcing agents. Of this benefit, $8.0 million, related to periods prior to fiscal 2011. Excluding this item, the adjusted net loss for the second quarter of 2011 was ($1.7) million, or ($0.02) per diluted share.
For the second quarter of fiscal 2012, net sales increased 4% to $485.3 million, from $468.2 million in the year ago period. Comparable sales, including the e-commerce channel, for the second quarter were essentially flat compared to a 12% decrease last year. Comparable store sales, excluding the e-commerce channel, for the second quarter decreased 1%, compared to a 14% decrease last year.
Thomas P. Johnson, Chief Executive Officer, commented, "While we were encouraged by the customer response to our fashion offering, we were disappointed by our overall financial performance for the second quarter. Our core basics business experienced significant pricing pressure due to the highly promotional and competitive retail landscape. As a result, we promoted these businesses more aggressively than initially expected to end the quarter with inventories inline with our plan."
E-commerce
Net revenue from the Company's e-commerce business for the second quarter of fiscal 2012 increased 27% to $31.9 million, from $25.1 million in the year ago period.
Cash Positioning and Share Repurchase Program
The Company ended the quarter with cash and cash equivalents of $169.6 million and no debt. The Company currently has $145.2 million of availability remaining under its share repurchase program.
Store Growth and Capital Spending
The Company opened seven Aeropostale and 15 P.S. from Aeropostale stores, and closed four Aeropostale stores during the quarter. For the second quarter, the Company invested $20.8 million in planned capital expenditures.
Third Quarter Guidance
Based on a soft start to the important back-to-school selling season, the Company expects earnings in the range of $0.25 to $0.30 per diluted share, compared to net earnings of $0.30 per diluted share in the same period last year.
Mr. Johnson continued, "While I believe we are focused on the right key initiatives to improve our overall business, sales trends for the early back-to-school season have been inconsistent. As we move through the remainder of the year, our entire organization is aligned and committed to executing on our strategic initiatives with a sense of urgency and determination."
Use of Non-GAAP Measures
The Company believes that the disclosure of adjusted net loss and adjusted loss per diluted share, which are non-GAAP financial measures, provides investors with useful information to help them better understand the Company's results (see Exhibit D).
Conference Call Information
The Company will be holding a conference call today at 4:15 P.M EDT to review its second quarter results. The broadcast will be available through the 'Investor Relations' link at www.aeropostale.com and www.fulldisclosure.com. To listen to the broadcast your computer must have Windows Media Player installed. If you do not have Windows Media Player go to the latter site prior to the call, where you can download the software for free.
Read more ...
Great work. dDT. Losers & gainers reposted x2.
Big Boards - Top Losers Thu Aug 16 - Source: finviz.com
[ 10%+ losers ]
IDIX Idenix Pharmaceuticals Inc. 5.84 -29.72%
AMCF Andatee China Marine Fuel Services Corporation 1.16 -28.83%
OTT Otelco Inc. 2.11 -17.58%
PERY Perry Ellis International Inc. 18.8 -15.58%
NTES NetEase.com, Inc. 49.56 -14.82%
UBCP United Bancorp Inc. 8.23 -12.73%
http://stockcharts.com/c-sc/sc?s=IDIX&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=AMCF&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=OTT&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=PERY&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=NTES&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=UBCP&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
Big Boards - Top Gainers Thu Aug 16 - Source: finviz.com
finviz.com reporting 160+ stocks over 5% gains today.
Top 25 charts posted.
20%+ gainers
CCRT CompuCredit Holdings Corp. 6.46 28.69%
AMCN AirMedia Group Inc. 2.39 25.79%
10%-20% gainers
PURE PURE Bioscience, Inc. 3.24 19.12%
GERN Geron Corporation 2.03 18.71%
BTH Blyth, Inc. 43.36 16.90%
GSV Gold Standard Ventures Corp 1.42 16.39%
BASI Bioanalytical Systems Inc. 1.26 15.82%
CFBK Central Federal Corp. 2.72 15.74%
BMTI BioMimetic Therapeutics Inc. 4.01 15.23%
VQ Venoco, Inc. 10.98 15.22%
CPSS Consumer Portfolio Services, Inc. 2.70 14.89%
LIVE LiveDeal, Inc. 5.60 14.52%
GTAT GT Advanced Technologies Inc. 6.14 13.91%
EVOL Evolving Systems Inc. 6.60 12.24%
TCX Tucows Inc. 1.21 12.04%
GALE Galena Biopharma, Inc. 1.72 10.97%
MDW Midway Gold Corp. 1.23 10.81%
SINA Sina Corp. 56.19 10.39%
HPOL Harris Interactive Inc. 1.28 10.34%
SRPT Sarepta Therapeutics, Inc. 10.15 10.33%
ACCO ACCO Brands Corporation 7.21 10.24%
MBND Multiband Corporation 1.85 10.12%
5%-10% gainers
UAMY United States Antimony Corp. 2.65 9.96%
PSTI Pluristem Therapeutics, Inc. 4.75 9.95%
BPAX BioSante Pharmaceuticals, Inc. 1.55 9.93%
ROYL Royale Energy Inc. 2.12 9.84%
CSCO Cisco Systems, Inc. 19.02 9.63%
CALX Calix Inc. 5.31 9.48%
SLCA U.S. Silica Holdings, Inc. 12.92 9.31%
SGYP Synergy Pharmaceuticals, Inc. 4.62 8.96%
CWST Casella Waste Systems Inc. 4.52 8.92%
PRKR Parkervision Inc. 2.34 8.84%
BLDR Builders FirstSource, Inc. 3.99 8.72%
OCZ OCZ Technology Group, Inc. 5.25 8.70%
PRIS Grupo Prisa SA 1.79 8.48%
PLCE The Children 55.90 8.40%
AMPE Ampio Pharmaceuticals, Inc. 2.87 8.30%
HILL Dot Hill Systems Corp. 1.18 8.26%
CLSN Celsion Corp. 3.85 8.15%
GPL Great Panther Silver Ltd 1.73 8.12%
ANAD Anadigics, Inc. 1.23 7.89%
CNTF China Techfaith Wireless Communication Technology Limited 1.10 7.84%
BAK Braskem S.A. 15.15 7.75%
SARA Saratoga Resources Inc. 6.01 7.71%
ONTY Oncothyreon Inc 4.63 7.67%
NLNK NewLink Genetics Corporation 13.89 7.59%
CSTR Coinstar, Inc. 51.88 7.59%
PPHM Peregrine Pharmaceuticals Inc. 2.84 7.58%
FIO Fusion-io, Inc. 28.23 7.50%
BZH Beazer Homes USA Inc. 2.91 7.38%
MPEL Melco Crown Entertainment Ltd. 11.50 7.38%
FFEX Frozen Food Express Industries Inc. 1.90 7.34%
DGIT Digital Generation, Inc. 9.32 7.25%
ES EnergySolutions, Inc 2.52 7.23%
EDMC Education Management Corporation 3.56 7.23%
NAVB Navidea Biopharmaceuticals, Inc 3.86 7.22%
EPHC Epoch Investment Partners, Inc. 22.74 7.21%
PAL North American Palladium Ltd. 1.64 7.19%
SWC Stillwater Mining Co. 9.73 7.16%
HMPR Hampton Roads Bankshares Inc. 1.96 7.10%
VOG Voyager Oil & Gas, Inc. 1.21 7.08%
TSON TranS1, Inc. 2.60 7.00%
CRMT America's Car-Mart Inc. 48.60 6.91%
PRSC Providence Service Corp. 11.83 6.87%
RYL Ryland Group Inc. 26.14 6.82%
GEVO Gevo, Inc. 3.95 6.76%
RSTI Rofin-Sinar Technologies Inc. 21.27 6.72%
PAAS Pan American Silver Corp. 16.38 6.71%
YNDX Yandex N.V. 21.46 6.61%
PRO PROS Holdings, Inc. 16.32 6.60%
ELX Emulex Corporation 7.11 6.60%
VRA Vera Bradley, Inc. 26.56 6.58%
PZZI Pizza Inn Holdings, Inc. 3.57 6.57%
AUMN Golden Minerals Company 4.72 6.55%
CCJ Cameco Corp. 22.53 6.52%
SHLD Sears Holdings Corporation 60.29 6.52%
SQNS Sequans Communications S.A. 1.80 6.51%
PHM PulteGroup, Inc. 13.60 6.42%
REGI Renewable Energy Group, Inc. 6.36 6.35%
GAME Shanda Games Limited 3.69 6.34%
HL Hecla Mining Co. 4.90 6.29%
PPP Primero Mining Corp. 4.23 6.28%
FN Fabrinet 12.70 6.28%
QTM Quantum Corporation 1.70 6.25%
ORCC Online Resources Corp. 2.39 6.22%
AVID Avid Technology, Inc. 9.09 6.19%
UCTT Ultra Clean Holdings Inc. 6.74 6.14%
GGAL Grupo Financiero Galicia S.A. 5.05 6.09%
FST Forest Oil Corp. 7.67 6.09%
CVH Coventry Health Care Inc. 34.71 6.08%
BRCD Brocade Communications Systems, Inc. 5.63 6.03%
PANW Palo Alto Networks, Inc. 66.50 6.01%
DSS Document Security Systems, Inc. 4.06 6.01%
CASC Cascade Corp. 49.91 5.99%
VITC Vitacost.com, Inc. 5.67 5.98%
BCEI Bonanza Creek Energy, Inc. 20.16 5.94%
INOD Innodata Isogen Inc. 3.58 5.92%
CRNT Ceragon Networks Ltd. 7.34 5.92%
GM General Motors Company 21.33 5.91%
CWEI Clayton Williams Energy Inc. 50.66 5.85%
ZINC Horsehead Holding Corp. 9.25 5.84%
WPP Wausau Paper Corp. 8.71 5.83%
FF FutureFuel Corp. 10.04 5.80%
EMKR EMCORE Corporation 5.30 5.79%
NG NovaGold Resources Inc. 4.76 5.78%
OMX OfficeMax Incorporated 5.32 5.77%
NBG National Bank of Greece SA 1.66 5.73%
DEPO DepoMed Inc. 5.35 5.73%
MX MagnaChip Semiconductor Corporation 14.21 5.73%
CIS Camelot Information Systems Inc. 2.03 5.73%
TGD Timmins Gold Corp. 2.22 5.71%
SONS Sonus Networks, Inc. 1.85 5.71%
SPRD Spreadtrum Communications Inc. 19.25 5.65%
FHCO The Female Health Company 6.19 5.63%
XRA Exeter Resource Corporation 1.69 5.63%
HOV Hovnanian Enterprises Inc. 2.64 5.60%
LRN K12, Inc. 21.93 5.58%
TOL Toll Brothers Inc. 32.16 5.58%
IPHI Inphi Corporation 11.43 5.54%
KBH KB Home 10.89 5.52%
VRNG Vringo, Inc. 3.25 5.52%
EA Electronic Arts Inc. 13.81 5.50%
ARX Aeroflex Holding Corp. 6.15 5.49%
KOF Coca-Cola FEMSA S.A.B de C.V. 121.81 5.46%
ASPS Altisource Portfolio Solutions S.A. 89.31 5.46%
GME GameStop Corp. 17.98 5.45%
QIHU Qihoo 360 Technology Co. Ltd 18.66 5.42%
BBY Best Buy Co. Inc. 20.41 5.42%
SNBC Sun Bancorp Inc. 2.92 5.42%
CORE Core-Mark Holding Company, Inc. 47.47 5.40%
PJC Piper Jaffray Companies 23.33 5.37%
CVGI Commercial Vehicle Group Inc. 9.03 5.37%
QUIK QuickLogic Corporation 2.17 5.34%
NSU Nevsun Resources Ltd. 3.77 5.31%
BRP Brookfield Residential Properties Inc. 12.99 5.27%
LTON Linktone Ltd. 1.80 5.26%
GHDX Genomic Health Inc. 36.10 5.25%
AMRI Albany Molecular Research Inc. 3.21 5.25%
TTWO Take-Two Interactive Software Inc. 9.87 5.22%
AGO Assured Guaranty Ltd. 14.11 5.22%
TC Thompson Creek Metals Company Inc. 2.42 5.22%
NNBR NN Inc. 9.12 5.19%
MUX McEwen Mining Inc. 3.47 5.15%
CCIX Coleman Cable, Inc. 9.60 5.15%
BSFT BroadSoft, Inc. 39.87 5.11%
TISI Team Inc. 31.88 5.11%
SID Companhia Siderurgica Nacional 5.35 5.11%
AVNW Aviat Networks, Inc. 2.47 5.11%
CRZO Carrizo Oil & Gas Inc. 25.99 5.10%
ULTA Ulta Salon, Cosmetics & Fragrance, Inc. 90.27 5.09%
RGEN Repligen Corporation 4.96 5.08%
TGB Taseko Mines Ltd. 2.69 5.08%
PC Panasonic Corporation 7.25 5.07%
VE Veolia Environnement S.A. 10.80 5.06%
CDE Coeur d'Alene Mines Corporation 21.02 5.05%
ALIM Alimera Sciences, Inc. 2.29 5.05%
LXRX Lexicon Pharmaceuticals, Inc. 2.29 5.05%
SREV ServiceSource Corporation 8.15 5.03%
EGT Entertainment Gaming Asia Inc. 2.30 5.02%
PGRX Prospect Global Resources, Inc. 2.93 5.02%
GFA Gafisa S.A. 3.56 5.01%
http://stockcharts.com/c-sc/sc?s=CCRT&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=AMCN&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=PURE&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=GERN&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=BTH&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=GSV&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=BASI&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=CFBK&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=BMTI&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=VQ&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=CPSS&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=LIVE&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=GTAT&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=EVOL&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=TCX&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=GALE&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=MDW&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=SINA&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=HPOL&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=SRPT&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=ACCO&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=MBND&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=UAMY&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=PSTI&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
http://stockcharts.com/c-sc/sc?s=BPAX&p=D&yr=0&mn=6&dy=0&i=p85310988516&a=270624201&r=1342041056464
STRM. after-close. Streamline Health Announces the Acquisition of Meta Health Technology
http://finance.yahoo.com/news/streamline-health-announces-acquisition-meta-200700811.html
PSTI. today. received permission from the Indian Ministry of Health to proceed with a Phase II clinical trial for the treatment of thromboangiitis obliterans (Buerger's disease).
http://ih.advfn.com/p.php?pid=nmona&article=53842049
8/13/12 Pluristem Moves Intermittent Claudication Indication Forward in Europe Through Collaboration With Cato Research
http://ih.advfn.com/p.php?pid=nmona&article=53794575
LUX. EyeMed Vision Care Call Center Scores Certification Hat Trick
Earns Third Consecutive Center of Excellence and Top 15 Recognition from BenchmarkPortal
http://finance.yahoo.com/news/eyemed-vision-care-call-center-192600598.html
Followers
|
2
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
531
|
Created
|
07/24/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |